HemaSphere (Jun 2022)
P466: AMPLIFIED EPOR/JAK2 GENES DEFINE A UNIQUE SUBTYPE OF ACUTE ERYTHROID LEUKEMIA
- J. Takeda,
- K. Yoshida,
- M. Nakagawa,
- Y. Nannya,
- A. Yoda,
- R. Saiki,
- Y. Ochi,
- L. Zhao,
- R. Okuda,
- X. Qi,
- T. Mori,
- A. Kon,
- K. Chiba,
- H. Tanaka,
- Y. Shiraishi,
- M.-C. Kuo,
- C. Kerr,
- Y. Nagata,
- D. Morishita,
- N. Hiramoto,
- A. Hangaishi,
- H. Nakazawa,
- K. Ishiyama,
- S. Miyano,
- S. Chiba,
- Y. Miyazaki,
- T. Kitano,
- K. Usuki,
- N. Sezaki,
- H. Tsurumi,
- S. Miyawaki,
- J. Maciejewski,
- T. Ishikawa,
- K. Ohyashiki,
- A. Ganser,
- M. Heuser,
- F. Thol,
- L.-Y. Shih,
- A. Takaori−Kondo,
- H. Makishima,
- S. Ogawa
Affiliations
- J. Takeda
- 1 Department of Pathology and Tumor Biology
- K. Yoshida
- 1 Department of Pathology and Tumor Biology
- M. Nakagawa
- 1 Department of Pathology and Tumor Biology
- Y. Nannya
- 1 Department of Pathology and Tumor Biology
- A. Yoda
- 1 Department of Pathology and Tumor Biology
- R. Saiki
- 1 Department of Pathology and Tumor Biology
- Y. Ochi
- 1 Department of Pathology and Tumor Biology
- L. Zhao
- 2 Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto
- R. Okuda
- 1 Department of Pathology and Tumor Biology
- X. Qi
- 1 Department of Pathology and Tumor Biology
- T. Mori
- 1 Department of Pathology and Tumor Biology
- A. Kon
- 1 Department of Pathology and Tumor Biology
- K. Chiba
- 3 Division of Genome Analysis Platform Development, National Cancer Center Research Institute
- H. Tanaka
- 4 M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan
- Y. Shiraishi
- 3 Division of Genome Analysis Platform Development, National Cancer Center Research Institute
- M.-C. Kuo
- 5 Division of Hematology−Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan
- C. Kerr
- 6 Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, United States of America
- Y. Nagata
- 6 Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, United States of America
- D. Morishita
- 7 Chordia Therapeutics Inc., Kanagawa
- N. Hiramoto
- 8 Department of Hematology, Kobe City Medical Center General Hospital, Kobe
- A. Hangaishi
- 9 Department of Hematology, NTT Medical Centre Tokyo, Tokyo
- H. Nakazawa
- 10 Department of Hematology, Shinshu University Hospital, Matsumoto
- K. Ishiyama
- 11 Department of Hematology, Kanazawa University, Kanazawa
- S. Miyano
- 4 M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan
- S. Chiba
- 12 Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba
- Y. Miyazaki
- 13 Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki
- T. Kitano
- 14 Department of Hematology, Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka
- K. Usuki
- 9 Department of Hematology, NTT Medical Centre Tokyo, Tokyo
- N. Sezaki
- 15 Department of Hematology, Chugoku Central Hospital, Hiroshima
- H. Tsurumi
- 16 Department of Hematology, Gifu University, Gifu
- S. Miyawaki
- 17 Division of Hematology, Tokyo Metropolitan Ohtsuka Hospital
- J. Maciejewski
- 6 Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, United States of America
- T. Ishikawa
- 8 Department of Hematology, Kobe City Medical Center General Hospital, Kobe
- K. Ohyashiki
- 18 Department of Hematology, Tokyo Medical University, Tokyo, Japan
- A. Ganser
- 19 Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
- M. Heuser
- 19 Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
- F. Thol
- 19 Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
- L.-Y. Shih
- 5 Division of Hematology−Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan
- A. Takaori−Kondo
- 20 Department of Hematology / Oncology, Kyoto University, Kyoto, Japan
- H. Makishima
- 1 Department of Pathology and Tumor Biology
- S. Ogawa
- 1 Department of Pathology and Tumor Biology
- DOI
- https://doi.org/10.1097/01.HS9.0000844752.28325.ee
- Journal volume & issue
-
Vol. 6
pp. 365 – 366
Abstract
No abstracts available.